Jubilant Cadista Recalls Methylprednisolone Tablets Due to Incorrect Expiration Date Labeling
Jubilant Cadista Pharmaceuticals is recalling 1,512 bottles of Methylprednisolone Tablets, USP, 16 mg, because the expiration date is printed incorrectly as 02/0218 instead of 02/2018.
The agency’s classification
FDA (Drugs): Class III
Class III is a situation in which use of or exposure to a violative product is not likely to cause adverse health consequences.
This is the agency’s own classification, taken from its notice. The severity score below is our assessment, not the agency’s. How recall classes work
What this means for you
Our assessment, not the agency’s: severity 1/5 (Low).
Cosmetic or documentation issue. No expected health impact, but the manufacturer is correcting the affected products.
Our severity reasoning: The FDA classified this as a Class III recall, which the rubric defines as typically resulting in a score of 1 or 2 because it is unlikely to cause adverse health consequences. The issue is a documentation/labeling error.
Plain-English summary
Jubilant Cadista Pharmaceuticals, Inc. is recalling 1,512 bottles of Methylprednisolone Tablets, USP, 16 mg, 50-count bottles, Rx only. The product is manufactured by Jubilant Cadista Pharmaceuticals Inc. in Salisbury, MD, and carries NDC 59746-003-14.
The recall is due to a labeling error where the expiration date is printed as 02/0218 instead of the correct date of 02/2018. The affected lot number is 16P0176. The FDA has classified this as a Class III recall, indicating that the product is unlikely to cause adverse health consequences.
The affected product was distributed nationwide and in Puerto Rico. Consumers and healthcare providers should check their inventory for this specific lot and expiration date error. As this is a prescription-only medication, patients should contact their healthcare provider or pharmacist for guidance on how to proceed.
The recalled product
- Product
- Methylprednisolone Tablets, USP, 16 mg, 50-count bottles, Rx only, Manufactured by Jubilant Cadista Pharmaceuticals Inc., Salisbury, MD 21801, NDC 59746-003-14.
- Manufacturer
- Jubilant Cadista Pharmaceuticals, Inc.
- Category
- Drug — Prescription Medication
- Hazard
- Affected units
- 1,512
Is your product affected?
Check your packaging against the codes below. If any of them match, the product is part of this recall.
Lot numbers (2)
- Lot #: 16P0176
- Exp 02/2018 but labeled incorrectly as 02/0218.
Distribution
Related recalls
Same manufacturer · Jubilant Cadista Pharmaceuticals, Inc.
See all →- Moderate
- HighJubilant Cadista Irbesartan tablets recalled due to failed dissolution
FDA (Drugs) · 2022-08-03
- HighIrbesartan Blood Pressure Tablets Recalled Due to Failed Dissolution
FDA (Drugs) · 2022-08-03
- ModerateFDA Voluntary Recall of Methylprednisolone Tablets for Subpotency
FDA (Drugs) · 2022-04-13
- SevereMeclizine Hydrochloride Tablets Recalled Due to Incorrect Label Mix-up
FDA (Drugs) · 2022-04-06
Same hazard · mis labeling
See all →- SevereWhite Vein Advanced Alkaloids Chewable Tablets Recall for Excess Active Ingredient
FDA (Food) · 2026-10-14
- SevereBetter Bakehouse Recalls Donutful Chocolate Dipped Vanilla Cake Donuts for Undeclared Milk
FDA (Food) · 2026-10-14
- HighFreshPoint Recalls Cranberry Chicken Salad Wedges for Undeclared Egg Allergen
FDA (Food) · 2026-10-14
- HighJ K Patisserie & Bakery LLC Recalls Croissants for Undeclared Egg
FDA (Food) · 2026-10-14
- LowMindray ePM Series Patient Monitor Manuals Recalled for Alarm Clarification
FDA (Devices) · 2026-10-14
Similar recalls
- LowJubilant Cadista Recalls Methylprednisolone Tablets Due to Illegible Labeling
FDA (Drugs) · 2021-03-10
- LowJubilant Cadista Recalls Methylprednisolone Tablets for Stability Failure
FDA (Drugs) · 2018-09-26
- ModerateFDA Voluntary Recall of Methylprednisolone Tablets for Subpotency
FDA (Drugs) · 2022-04-13
- SevereMeclizine Hydrochloride Tablets Recalled Due to Incorrect Label Mix-up
FDA (Drugs) · 2022-04-06
- LowJubilant Cadista Recalls Valsartan Tablets Due to Potential Excipient Error
FDA (Drugs) · 2018-08-29
- ModerateJubilant Cadista Recalls Pantoprazole Sodium Tablets Due to Manufacturing Deviations
FDA (Drugs) · 2013-05-08